why choose us

First received: December 01, 2022

Clinical Trial: Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA

Study Status: Completed

Recruit Status: RECRUITING

Condition: ABPA

Study Type: INTERVENTIONAL


Official Title: Study to Evaluate the Effect of Dose and Duration of Treatment of Itraconazole Administered as a Dry Powder for Inhalation (PUR1900) on Safety, Tolerability, and Potential Outcomes in Adult Patients W

Brief Summary: The goal of this clinical trial is to learn about PUR1900 as an inhaled, antifungal therapeutic for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in patients with asthma.The main questions it aims to answer are:Is PUR1900 safe and well tolerated in adults with asthma and ABPA?Is there an effect of daily administration of PUR1900 on potential outcome measures in adults with asthma and ABPA?Is there fungal resistance to A. fumigatus?This study includes a 28-day screening period, a 112-day (16-week)…

Read more